The rapid development of high accuracy and high sensitivity mass spectrometry technologies has
revolutionized our understanding of proteins and their contribution to cellular
function. However, there is an increasingly apparent disconnect between these
state-of-the-art tools and their effective applications to advance
cardiovascular biology and medicine. Despite progress made in certain areas of
investigation, cardiovascular proteomic research faces three major challenges:
the excessive cost of instrumentation; the limited accessibility of advanced
proteomic technology to the cardiovascular community at large; and the
overwhelming quantity and fragmented nature of mass spectra datasets lacking
functional annotations. These economic, technological, and informatic
limitations are prohibitive to further advancement of the field.
To move the field forward, our investigator team identified several key challenges that commonly
surround mass spectrometer data processing and non-targeted database searches.
Accordingly, we propose the construction of a Cardiac-specific Organellar Peptide
Spectral (COPa) Library, which will provide a specialized, comprehensive, and
interactive resource for the cardiovascular community. We aim to engineer a
robust and high fidelity library to enable targeted peptide data searches with
functional annotations. This library will catalogue experimental peptide spectra
obtained from cardiovascular organelles of various species; it will contain a
Wiki-like web interface to engage the participation of the cardiovascular
community; and it will build a cardiovascular proteome knowledgebase with
efforts from proteomic scientists, biologists, and cardiovascular clinicians.
In summary, this COPa Library will create an essential tool box to support the
translation of proteomic data into the advancement of cardiovascular biology and
medicine; it will bridge the gap between traditional data-driven proteomic
studies and hypothesis-driven investigations widely employed by the
cardiovascular community, propelling innovation and new discoveries.